Document Preview Unavailable

Indirect Comparison Between Bimekizumab and Brodalumab for the Management of Moderate to Severe Psoriasis: A 36-Week Real-Life Study

Potestio, Luca; Martora, Fabrizio; Raia, Flavia; Lucagnano, Gioacchino; Brescia, Claudio; et al.  Dermatology and Therapy Vol. 15, Iss. 3,  (Mar 2025): 721-731.

You might have access to this document